Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734279 · ClinicalTrials.gov registry record · Early Phase 1
Follicle-Stimulating Hormone (FSH) and the Onset of Puberty
A Early Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT00734279: Completed Early Phase 1 study, sponsored by University of Utah.
NCT00734279 is a Early Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 11 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00734279, a Early Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the timing of the onset of puberty may be affected by FSH-regulatory peptides. We will determine how these peptides relate to FSH production in prepubertal and pubertal children by comparing the regulation of FSH control in children with precocious (early) puberty and delayed puberty. In this pilot study, we will stimulate the pubertal axis using an agonist of GnRH to determine the pubertal response of activin-A, inhibin-A and -B and follistatin. To determine baseline FSH secretion and FSH-regulatory peptide tone, we will block GnRH with a specific antagonist. These studies should lead to a better understanding of the role of FSH in controlling the onset of puberty and the pathogenesis of pubertal disorders.
Interventions
- DRUG Leuprolide Acetate - Early Puberty Leuprolide Visit
- DRUG Ganirelix - Early Puberty Ganirelix Visit
- DRUG Ganirelix - Delayed Puberty Ganirelix Visit
- DRUG Leuprolide Acetate- Delayed Puberty Leuprolide Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2006-03 |
| Est. Completion | 2010-12 |
| Phase | Early Phase 1 |
What the finished NCT00734279 record still lists
NCT00734279 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 4 interventions - of which Leuprolide Acetate - Early Puberty Leuprolide Visit is the first listed.
NCT00734279 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00734279 about?
NCT00734279 is a clinical study titled "Follicle-Stimulating Hormone (FSH) and the Onset of Puberty". The purpose of this study is to determine if the timing of the onset of puberty may be affected by FSH-regulatory peptides. We will determine how these peptides relate to FSH production in prepubertal and pubertal children by comparing the regulation of FSH control in children with precocious (earl...
What is the current status of trial NCT00734279?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2006-03. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00734279?
The interventions under investigation include: Leuprolide Acetate - Early Puberty Leuprolide Visit (DRUG), Ganirelix - Early Puberty Ganirelix Visit (DRUG), Ganirelix - Delayed Puberty Ganirelix Visit (DRUG), Leuprolide Acetate- Delayed Puberty Leuprolide Visit (DRUG).
Who is sponsoring clinical trial NCT00734279?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00734279's enrollment target sits among peer trials
11 1601st of 2000 higher than 373 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia